• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺肽α1对人淋巴细胞增殖的增强作用并非由前列腺素E2介导。

Thymosin alpha 1 enhancement of human lymphocyte proliferation is not mediated by prostaglandin E2.

作者信息

Colarian J, Sethi A, Merchant A, Parikh N, Mutchnick M

机构信息

Department of Medicine, Wayne State University School of Medicine, Detroit, MI.

出版信息

Thymus. 1990 Jun;15(4):241-7.

PMID:2368121
Abstract

Prostaglandins of the E series have been implicated as possible mediators of thymosin alpha 1 (TA-1) effect on mitogen stimulated lymphoproliferation. In the present study human peripheral blood mononuclear cells were stimulated with concanavalin A in the presence of TA-1, prostaglandin E2 and indomethacin individually, or in combination. Both TA-1 and indomethacin significantly enhanced the proliferative response over that seen with mitogen alone (less than 0.001). The magnitude of enhancement observed with indomethacin (20 microM) was considerably less than that of TA-1 and it was abolished with prostaglandin E2. The combination of indomethacin and TA-1 did not alter TA-1 effect and prostaglandin E2 (up to 250 ng/ml) did not abolish thymosin effect. These results suggest that TA-1 and prostaglandin E2 have opposite effects and that thymosin enhancement of mitogen induced proliferation is not mediated by prostaglandin E2.

摘要

E 系列前列腺素被认为可能是胸腺肽α1(TA-1)对有丝分裂原刺激的淋巴细胞增殖产生作用的介质。在本研究中,分别或联合使用 TA-1、前列腺素 E2 和吲哚美辛,在伴刀豆球蛋白 A 存在的情况下刺激人外周血单个核细胞。与单独使用有丝分裂原相比,TA-1 和吲哚美辛均显著增强了增殖反应(P<0.001)。观察到吲哚美辛(20μM)的增强幅度明显小于 TA-1,且前列腺素 E2 可消除该增强作用。吲哚美辛与 TA-1 的联合使用未改变 TA-1 的作用,且前列腺素 E2(高达 250 ng/ml)未消除胸腺肽的作用。这些结果表明,TA-1 和前列腺素 E2 具有相反的作用,且胸腺肽对有丝分裂原诱导增殖的增强作用不是由前列腺素 E2 介导的。

相似文献

1
Thymosin alpha 1 enhancement of human lymphocyte proliferation is not mediated by prostaglandin E2.胸腺肽α1对人淋巴细胞增殖的增强作用并非由前列腺素E2介导。
Thymus. 1990 Jun;15(4):241-7.
2
Suppressive effect of thymosin fraction 5 on proliferation of cultured human T lymphocytes.胸腺素5组分对培养的人T淋巴细胞增殖的抑制作用。
Immunopharmacology. 1986 Dec;12(3):233-40. doi: 10.1016/0162-3109(86)90007-x.
3
Effects exerted by prostaglandins and indomethacin on the immune response during aging.前列腺素和吲哚美辛对衰老过程中免疫反应的影响。
Gerontology. 1986;32(1):1-9. doi: 10.1159/000212759.
4
In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.前列腺素E2对III期黑色素瘤患者外周血淋巴细胞白细胞介素-2产生的体外抑制作用:外源性白细胞介素-2加吲哚美辛对淋巴细胞增殖的增强作用。
J Biol Response Mod. 1986 Feb;5(1):12-9.
5
Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.特应性皮炎中淋巴细胞转化受抑制及前列腺素的作用
Clin Exp Immunol. 1990 Mar;79(3):380-4. doi: 10.1111/j.1365-2249.1990.tb08099.x.
6
Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.前列腺素对体外有丝分裂原刺激淋巴细胞的抑制作用。随有丝分裂原剂量及预孵育的变化
J Clin Invest. 1978 Oct;62(4):753-60. doi: 10.1172/JCI109186.
7
Regulation of human immunoglobulin production in vitro by prostaglandin E2.前列腺素E2对体外人免疫球蛋白产生的调节作用。
Clin Exp Immunol. 1982 Jul;49(1):115-22.
8
Contrasting effects of prostaglandin E2 and indomethacin in modulating Con A-induced human lymphocyte proliferation and suppressor cell development.前列腺素E2和消炎痛在调节刀豆蛋白A诱导的人淋巴细胞增殖及抑制细胞发育中的对比作用
Clin Immunol Immunopathol. 1982 Oct;25(1):32-42. doi: 10.1016/0090-1229(82)90162-3.
9
Is thymosin action mediated by prostaglandin release?胸腺素的作用是由前列腺素释放介导的吗?
Science. 1983 Jun 10;220(4602):1163-4. doi: 10.1126/science.6574601.
10
Effects of anti-tuberculosis drugs on the production of prostaglandin E2 and on mononuclear leucocyte transformation.抗结核药物对前列腺素E2生成及单核白细胞转化的影响。
Chemotherapy. 1987;33(3):204-10. doi: 10.1159/000238496.